Welcome : Guest

StemCells, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about StemCells, Inc., which is principally involved in Stem Cell Therapeutics Business. Illustrated with 33 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

Code: PCP-65440
Price: $1650
Company Type: Public
Pages: 35
Date: January 2016
Market Data Tables: 33

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Stem Cells Market......2
Table 1: Autologous Stem Cell Market by Disease Worldwide (2014) – Percentage Share Breakdown by Value for Infection, New Malignancy, Organ Failure, Primary Disease and Others......2
Table 2: Unrelated Donor Stem Cells Market by Disease Worldwide (2014) – Percentage Share Breakdown by Value for Graft-Versus-Host Disease, Infection, New Malignancy, Organ Failure, Primary Disease and Others......3
Table 3: Bone Marrow Stromal Cells by Type Worldwide (2015) - Percentage Market Share Breakdown by Value for CD34+ and CD31-, Ebdothelial Cells, Stem Cells, Tissue Macrophages, Vascular Smooth Muscle Cells, and White Blood Cells......4
Table 4: Human Leukocyte Antigen (HLA) - Identical Sibling Stem Cell Market by Disease Worldwide (2014) - Percentage Share Breakdown by Value for Graft-Versus-Host Disease, Infection, New Malignancy, Organ Failure, Primary Disease and Others......5
Stem Cell Transplantation Market......6
Table 5: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Acute Leukemia by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......6
Table 6: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Bone Marrow Failure by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......7
Table 7: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Chronic Leukemia by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......8
Table 8: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Leukemias by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......9
Table 9: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Lymphoma by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......10
Table 10: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Lymphoproliferative by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......11
Table 11: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Mixed Myelodysplastic and Myeloproliferative Syndromes (MDS/MPS) by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......12
Table 12: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Non-Malignant Disorders by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......13
Table 13: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Plasma Cell Disorders by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......14
Table 14: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Solid Tumors by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......15
Table 15: Transplant Market by Cell Source Worldwide (2014) - Percentage Share Breakdown by Value for Bone Marrow, Cord Blood and Peripheral Blood Stem Cell......16
Table 16: Bone Marrow Transplantation by Region Worldwide (2014) - Percentage Market Share Breakdown by Volume Sales for US, and Others......17
Table 17: Haematopoietic Stem Cell Transplantation (HSCT) Market by Region Worldwide (2015) - Percentage Share Breakdown by Volume for European Union, United States and Rest Of World......18
Table 18: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Market by Category in Americas (2015) - Percentage Share Breakdown by Value for Acute Leukemia, Chronic Leukemia, Leukemias, Lymphoma, Lymphoproliferative, Mixed Myelodysplastic and Myeloproliferative Syndromes (MDS/MPS) and Others......19
Table 19: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Market by Category in Europe (2015) - Percentage Share Breakdown by Value for Acute Leukemia, Leukemias, Lymphoma, Lymphoproliferative, Mixed Myelodysplastic and Myeloproliferative Syndromes (MDS/MPS), Non-Malignant Disorders and Others......20
Table 20: Number of β-thalassemia Patients for Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) by Category in Europe (2015) - Percentage Market Share Breakdown by Volume for Bone Marrow (BM), Mixed Chimerism, Peripheral Blood (PB), Unrelated Cord Blood Transplantation (UCB) and Uterine Natural Killer (UNK)......21
Table 21: Adult Recipients (18+ years) Transplant Market by Cell Source in Japan (2014) - Percentage Share Breakdown by Volume for Bone Marrow, Cord Blood and Peripheral Blood Stem Cells......22
Table 22: Paediatric Recipients (<18 Years) Transplant Market by Cell Source in Japan (2014) - Percentage Share Breakdown by Volume for Bone Marrow, Cord Blood and Peripheral Blood Stem Cells......23
Table 23: Stem Cell Transplantation Market by Category for American Indian and Alaskan Natives in the US (2015) - Percentage Market Share Breakdown by Volume for Bone Marrow of Periperal Blood and Cord Blood......24
Table 24: Stem Cell Transplantation Market by Category for Asians in the US (2015) - Percentage Share Breakdown by Volume for Bone Marrow of Periperal Blood and Cord Blood......25
Table 25: Stem Cell Transplant Market by Category for Black and African Americans in the US (2015) - Percentage Market Share Breakdown by Volume for Bone Marrow of Periperal Blood and Cord Blood......26
Table 26: Stem Cell Transplantation Market by Category for Native Hawalian and Other Pacific Islanders in the US (2015) - Percentage Share Breakdown by Volume for Bone Marrow of Periperal Blood and Cord Blood......27
Table 27: Stem Cell Transplantation Market by Category for Whites in the US (2015) - Percentage Share Breakdown by Volume for Bone Marrow of Periperal Blood and Cord Blood......28
Single Cell Omics......29
Table 28: Single Cell Omics Market by Application (2012-2017) in US$ Million for Subpopulation Characterization, Genomic Variation, Cell Differentiation/Reprograming, Method, Circulating Cells, and Others......29
Table 29: Single Cell Omics Market by Field of Study (2012-2017) in US$ Million for Basic Cell Biology, Immunology, Microbiology, Neurology, Oncology, Stem Cell Biology, and Others......30
Table 30: Single Cell Omics Market by Product (2012-2017) in US$ Million for Instruments, and Reagents......31
Table 31: Single Cell Omics Market by Region/Country (2012-2017) in US$ Million for US, Europe, Asia-Pacific (Excl. Japan), Japan, and Rest of the World......32
Table 32: Single Cell Omics Market by Technology (2012-2017) in US$ Million for qPCR, NGS Sequencing, Microarrays, PCR, and Others......33
Table 33: Single Cell Omics Market Share by Customer Type - 2016E......34